TSHA
TSHA
US8776191061
Taysha Gene Therapies, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 9.773.000 8.333.000
17.3%
Cost of Revenue -- --
--
Gross Profit -- --
--
120.271.000 94.954.000
26.7%
Operating Income -110.498.000 -86.621.000
27.6%
Pretax Income -108.995.000 -89.298.000
22.1%
Net Income Common Stockholders -108.995.000 -89.298.000
22.1%
-- --
--
-- --
--
ende